Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) EBIT: 2020

Historic EBIT for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$8.3 million.

  • Design Therapeutics' EBIT was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
  • Design Therapeutics' EBIT amounted to -$8.3 million in FY2020.
  • In the past 5 years, Design Therapeutics' EBIT registered a high of -$8.3 million during FY2020, and its lowest value of -$8.3 million during FY2020.
  • For the 1-year period, Design Therapeutics' EBIT averaged around -$8.3 million, with its median value being -$8.3 million (2020).